Atlas FDA

NHT

6 FDA 510(k) clearances · Product code

92 daysmedian time to decision
144 days90th percentile
6clearances measured

FDA profile

Official device name
Assay, Nucleic Acid Amplification, Bacillus Anthracis
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3045
Medical specialty
Microbiology
FDA definition
An invitro diagnostic device used to presumptively detect the presence or absence of b. Anthracis directly in blood specimens or suspicious culture growth.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
B. anthracis Real-time PCR Assay (K192871)Centers for Disease Control and Prevention2019-11-07
ANTHRACIS REAL-TIME PCR ASSAY (K140426)Centers For Disease Control and Prevention (CDC)2014-05-22
JBAIDS ANTHRAX DETECTION KIT (K131930)Biofire Diagnostics, Inc.2013-08-05
JBAIDS PLAQUE DETECTION KIT, MODEL JRPD-ASY-0123 (K072631)Idaho Technology, Inc.2007-12-20
MODIFICATION TO JBAIDS ANTHRAX DETECTION SYSTEM (K071188)Idaho Technology, Inc.2007-05-21
JBAIDS ANTHRAC DETECTION SYSTEM (K051713)Idaho Technology, Inc.2005-11-18

Track NHT automatically

Every clearance here is in the API, with alerts when new ones post.